Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase
- 1 January 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 292 (1), F313-F320
- https://doi.org/10.1152/ajprenal.00180.2006
Abstract
Kidney injury molecule-1 (Kim-1) is associated with ischemic and proteinuric tubular injury; however, whether dysregulation of the renin-angiotensin system (RAS) can also induce Kim-1 is unknown. We studied Kim-1 expression in homozygous Ren2 rats, characterized by renal damage through excessive RAS activation. We also investigated whether antifibrotic treatment (RAS blockade or p38 MAP kinase inhibition) would affect Kim-1 expression. At 7 wk of age, homozygous Ren2 rats received a nonhypotensive dose of candesartan (0.05 mg·kg−1·day−1 sc) or the p38 inhibitor SB-239063 (15 mg·kg−1·day−1 sc) for 4 wk; untreated Ren2 and Sprague-Dawley (SD) rats served as controls. Kim-1 mRNA and protein expression were determined by quantitative PCR and immunohistochemistry, respectively, and related to markers of prefibrotic renal damage. Urinary Kim-1 was measured in 8-wk-old Ren2 and SD rats with and without angiotensin-converting enzyme inhibition (ramipril, 1 mg·kg−1·day−1 in drinking water for 4 wk). Untreated Ren2 rats showed a >20-fold increase in renal Kim-1 mRNA (expressed as Kim-1-to-GAPDH ratio): 75.5 ± 43.6 vs. 3.1 ± 1.0 in SD rats ( P < 0.01). Candesartan and SB-239063 strongly reduced Kim-1 mRNA: 3.1 ± 1.5 ( P < 0.01) and 9.8 ± 4.2 ( P < 0.05), respectively. Kim-1 protein expression in damaged tubules paralleled mRNA expression. Kim-1 expression correlated with renal osteopontin, α-smooth muscle actin, and collagen III expression and with tubulointerstitial fibrosis. Damaged tubular segments expressing activated p38 also expressed Kim-1. Urinary Kim-1 was increased in Ren2 vs. SD (458 ± 70 vs. 27 ± 2 pg/ml, P < 0.01) rats and abolished in Ren2 rats treated with ramipril (33 ± 5 pg/ml, P < 0.01). Kim-1 is associated with development of RAS-mediated renal damage. Antifibrotic treatment through RAS blockade or p38 MAP kinase inhibition reduced Kim-1 in the homozygous Ren2 model.Keywords
This publication has 25 references indexed in Scilit:
- Mitogen activated protein kinase signaling in the kidney: target for intervention?Signal Transduction, 2006
- The role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseKidney International, 2005
- Tubulointerstitial damage and progression of renal failureKidney International, 2005
- Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protectionCardiovascular Research, 2005
- Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell CarcinomaJournal of the American Society of Nephrology, 2005
- p38-MAPK inhibition and endotoxin induced tubular dysfunction in menInnate Immunity, 2004
- p38-MAPK inhibition and endotoxin induced tubular dysfunction in menInnate Immunity, 2004
- Cell-type-specific activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in ratsBiochemical and Biophysical Research Communications, 2004
- Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse KidneyJournal of Biological Chemistry, 2003
- Renal injury from angiotensin II-mediated hypertension.Hypertension, 1992